Vaccines Market Major Key Players are covered by Reports and Data

Posted by rutikashete on May 14th, 2021

Increasing government funding for vaccine production and growing emphasis on immunization are major factors expected to drive the market

Vaccines Market Size – USD 42 Billion in 2020, Market Growth – 7.3% Market Trends – Expanding pharmaceutical industry and drive to vaccinate all

The global Vaccines Market size is expected to reach USD 73.78 billion by 2028, registering a CAGR of 7.3% over the forecast period, according to the latest report by Reports and Data. Major factors driving market revenue growth are rising prevalence of infectious diseases, increasing government funding for vaccine production, and growing emphasis on immunization.

Immunization is a public health and development success storey that saves millions of lives each year. By bolstering the body's natural defences, vaccines reduce the chances of developing a disease. Vaccination helps avoid over 20 life-threatening diseases, helping people of all ages to live longer, healthier lives. Vaccines save lives of 2-3 million people per year from diseases such as diphtheria, tetanus, pertussis, influenza, and measles.

Immunization is a basic human right and an essential component of primary health care. Over the past decade, more than 1 billion children have been vaccinated. Vaccines are essential for preventing and managing outbreaks of infectious diseases. They're crucial in battle against antimicrobial resistance, and for global health protection. The Global Vaccine Action Plan (GVAP), which was endorsed by the 194 Member States of the World Health Assembly in May 2012, is a framework for avoiding millions of deaths by 2020 by ensuring that people from all walks of life have equal access to current vaccines.

Millions of people worldwide have recently been infected with the COVID-19 disease. Community transmission has resulted in rising fatalities in some regions. In 2021, biopharmaceutical and biotech companies succeeded in bringing to market an effective vaccine against the virus that causes SARS-Cov-2. The coronavirus outbreak has sparked unprecedented demand and businesses are investing heavily in R&D activities along with government to meet the growing demand for COVID-19 vaccines. This is expected to boost the market's growth prospects.

Despite tremendous progress, various people around the world, including nearly 20 million babies last year, still lack access to vaccines. In some countries, progress has stalled or even reversed, and there is a real risk that complacency will undo previous achievements. Furthermore, high storage and transportation costs for vaccines can stifle market supply. These factors are expected to hamper the revenue growth of the vaccines market to a certain extent going ahead.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4023

Some Key Highlights in the Report:

•          The conjugate vaccines segment had the largest share of the vaccines market in 2020. Increased government funding and growing company investments in conjugate vaccine production are attributable to this segment's large share.
•          Owing to growing immunization concerns against a number of predominant infectious diseases, which are a major cause of mortality and morbidity, most disease indication segments have registered considerable growth.
•          The intramuscular and subcutaneous administration segment accounted for the largest revenue share in the vaccines market in 2020.
•          The pediatric patients segment accounted for the largest revenue share among other patient type segments in 2020.
•          In 2020, North America held the largest revenue share in the vaccines market. The regional growth can be attributed to increased public awareness of the risks of infectious diseases as well as increased government and non-government expenditures on vaccine production and widespread distribution.
•          The fastest growth is expected in the Asia Pacific region over the forecast period, owing to a rising target population base with high unmet clinical needs.
•          The major players in the global vaccines market are GlaxoSmithKline plc, Pfizer, Inc, Merck & Co., Inc. and Sanofi Pasteur, CSL Limited, Emergent BioSolutions, Inc., Johnson & Johnson, Serum Institute of India, AstraZeneca, Bavarian Nordic , Mitsubishi Tanabe Pharma Corporation, and Daiichi Sankyo Company, Limited.

Segments Covered in the Report

For the purpose of this study, Reports and Data has segmented the global vaccines market on the basis of technology, type, disease indication, route of administration, patient type, and region:

Technology Outlook (Revenue, USD Billion, 2018 - 2028)

•          Conjugate vaccines
•          Inactivated and subunit vaccines
•          Live attenuated vaccines
•          Recombinant vaccines
•          Toxoid vaccines

Type Outlook (Revenue, USD Billion, 2018 - 2028)

•          Monovalent vaccines
•          Multivalent vaccines

Disease Indication Outlook (Revenue, USD Billion, 2018 - 2028)

•          Pneumococcal disease
•          DTP
•          Influenza
•          HPV
•          Meningococcal disease
•          Polio
•          Rotavirus
•          Hepatitis
•          MMR
•          Varicella
•          Herpes zoster
•          Other disease indications

Route of Administration Outlook (Revenue, USD Billion, 2018 - 2028)

•          Intramuscular and subcutaneous administration
•          Oral administration
•          Other routes of administration

Patient Type Outlook (Revenue, USD Billion, 2018 - 2028)

•          Pediatric patients
•          Adult patients

Regional Outlook (Revenue, USD Billion, 2018 - 2028)

•          North America

o    U.S.

o    Canada

•          Europe

o    Germany

o    UK

o    France

o    Italy

o    Spain

o    Rest of Europe

•          Asia Pacific

o    China

o    India

o    Japan

o    Rest of Asia Pacific

•          Latin America

o    Brazil

o    Rest of Latin America

•          MEA

o    South Africa

o    Saudi Arabia

o    Rest of MEA

Key Highlights of the Vaccines Market Report:

•          Extensive research of growth patterns, market size and share, top companies, and key segments of the global Vaccines market
•          Detailed information on market trends, driving factors, restraining factors, product segmentation, and industry chain analysis
•          Thorough regional analysis and competitive landscape
•          Key statistical data organized in tables, charts, figures, and other pictorial representation
•          SWOT analysis and Porter’s Five Forces analysis for each key player

Table of Content:

Chapter 1 Introduction 
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope 
           1.3.1 Market Covered
           1.3.2 Years Considered for the Study
    1.4 Currency 
    1.5 Limitations
    1.6 Stakeholders
Chapter 2 Research Methodology  
    2.1 Research Approach 
           2.1.1 Secondary Research
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Research
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Market Size Estimation
    2.3 Data Triangulation Approach
    2.4 Market Share Analysis
    2.5 Assumptions for the Study 
Chapter 3 Executive Summary 
Chapter 4 Premium Insights 
    4.1 Vaccines Market Overview 
    4.2 North America: Vaccines Market, By Technology (2018)
    4.3 Geographical Snapshot of the Vaccines Market 
Chapter 5 Market Overview
    5.1 Introduction 
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 High Prevalence of Infectious Diseases
                    5.2.1.2 Rising Focus on Immunization Programs
                    5.2.1.3 Growing Government Support for Vaccine Development
                    5.2.1.4 Increasing Company Initiatives to Enhance Vaccine R&D
           5.2.2 Restraints
                    5.2.2.1 High Cost of Vaccine Development
           5.2.3 Opportunities
                    5.2.3.1 High Growth Prospects in Emerging Markets
                    5.2.3.2 Focus on Therapeutic Vaccines
                    5.2.3.3 Use of Adjuvants in Vaccines
           5.2.4 Challenges
                    5.2.4.1 Inadequate Access to Vaccines
           5.2.5 Burning Issues
                    5.2.5.1 Product Recalls
Chapter 6 Industry Insights

Continued….

Thank you for reading our report. Customization of the report is available based on the client’s requirements. For more details, kindly connect with us, and our team will ensure the report is suited to meet your requirements.